|
choline alfoscerate |
|
CHEBI:16870 |
|
A member of the class of phosphocholines that is the choline ester of sn-glycero-3-phosphate. It is one of the major osmolyte in the renal medullary cells. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
Birgit
|
|
CHEBI:76433, CHEBI:41458, CHEBI:10646, CHEBI:12847, CHEBI:12841, CHEBI:26697, CHEBI:55397, CHEBI:14343
|
|
ChemicalBook:CB8742186, ChemicalBook:CB64796923, eMolecules:514488, ZINC000003645145 |
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
Leucine (symbol Leu or L) is an essential amino acid that is used in the biosynthesis of proteins. Leucine is an α-amino acid, meaning it contains an α-amino group (which is in the protonated −NH3+ form under biological conditions), an α-carboxylic acid group (which is in the deprotonated −COO− form under biological conditions), and a side chain isobutyl group, making it a non-polar aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it; it must be obtained from the diet. Human dietary sources are foods that contain protein, such as meats, dairy products, soy products, and beans and other legumes. It is encoded by the codons UUA, UUG, CUU, CUC, CUA, and CUG. Leucine is named after the Greek word for "white": λευκός (leukós, "white"), after its common appearance as a white powder, a property it shares with many other amino acids.
Like valine and isoleucine, leucine is a branched-chain amino acid. The primary metabolic end products of leucine metabolism are acetyl-CoA and acetoacetate; consequently, it is one of the two exclusively ketogenic amino acids, with lysine being the other. It is the most important ketogenic amino acid in humans.
Leucine and β-hydroxy β-methylbutyric acid, a minor leucine metabolite, exhibit pharmacological activity in humans and have been demonstrated to promote protein biosynthesis via the phosphorylation of the mechanistic target of rapamycin (mTOR). |
Read full article at Wikipedia
|
InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1 |
SUHOQUVVVLNYQR-MRVPVSSYSA-N |
C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Saccharomyces cerevisiae
(NCBI:txid4932)
|
Source: yeast.sf.net
See:
PubMed
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
parasympatholytic
Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
parasympatholytic
Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
View more via ChEBI Ontology
(2R)-2,3-dihydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate
|
2- {[(2R)- 2,3- dihydroxypropoxy](hydroxy)phosphoryloxy}- N,N,N- trimethylethanaminium
|
alfoscerate de choline
|
ChemIDplus
|
alfoscerato de colina
|
ChemIDplus
|
choline alfoscerate
|
ChemIDplus
|
choline alfoscerate
|
KEGG DRUG
|
cholini alfosceras
|
ChemIDplus
|
(2R)-2,3-dihydroxypropyl 2-(trimethylammonio)ethyl phosphate
|
IUPAC
|
alpha-Glycerophosphorylcholine
|
HMDB
|
Choline alphoscerate
|
ChemIDplus
|
Choline glycerophosphate
|
ChemIDplus
|
Cholini glycerophosphas
|
ChemIDplus
|
Glicerofosfato de colina
|
ChemIDplus
|
Glycerol phosphorylcholine
|
HMDB
|
Glycerol-3-phosphatidylcholine
|
HMDB
|
glycerol-3-phosphocholine
|
ChEBI
|
Glycerophosphate de choline
|
ChemIDplus
|
Glycerophosphocholine
|
ChemIDplus
|
Glycerophosphocholine
|
KEGG COMPOUND
|
Glycerophosphocholine
|
KEGG COMPOUND
|
Glycerophosphorylcholine
|
ChemIDplus
|
GPCho
|
HMDB
|
L-alpha-Glycerophosphocholine
|
ChemIDplus
|
L-alpha-Glycerophosphorylcholine
|
ChemIDplus
|
L-alpha-Glycerophosphorylcholine
|
HMDB
|
L-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphate inner salt
|
HMDB
|
sn-3-GPC
|
MetaCyc
|
sn-Glycero-3-phosphocholine
|
ChemIDplus
|
sn-glycero-3-phosphocholine
|
ChEBI
|
sn-glycero-3-phosphocholine
|
ChEBI
|
sn-glycerol 3-phosphocholine
|
UniProt
|
28319-77-9
|
CAS Registry Number
|
ChemIDplus
|
28319-77-9
|
CAS Registry Number
|
KEGG DRUG
|
3908444
|
Reaxys Registry Number
|
Reaxys
|
6062450
|
Beilstein Registry Number
|
Beilstein
|
21165396
|
PubMed citation
|
Europe PMC
|
21195433
|
PubMed citation
|
Europe PMC
|
22191561
|
PubMed citation
|
Europe PMC
|
22677751
|
PubMed citation
|
Europe PMC
|
22679745
|
PubMed citation
|
Europe PMC
|
22959283
|
PubMed citation
|
Europe PMC
|
23013274
|
PubMed citation
|
SUBMITTER
|
23244432
|
PubMed citation
|
Europe PMC
|
23268258
|
PubMed citation
|
Europe PMC
|
23314552
|
PubMed citation
|
Europe PMC
|
23387341
|
PubMed citation
|
Europe PMC
|
23528493
|
PubMed citation
|
Europe PMC
|
24156263
|
PubMed citation
|
Europe PMC
|
24166560
|
PubMed citation
|
Europe PMC
|
6420466
|
PubMed citation
|
Europe PMC
|
|